ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Medicare Cuts Payments To Physicians By 21%. House Bill Would Mandate Medicare Coverage Of CT Scans For Colorectal Cancer Screening

June 4, 2010

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008

AACR Elects Officers.

April 9, 2010

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997